Bempedoic acid (ETC-1002), an ACLY inhibitor, was found to induce apoptosis and inhibit cancer cell invasion, and in combination with palbociclib (a CDK4/6 inhibitor), it significantly reduced cell viability in a panel of breast and pancreatic cancer cell lines [87]. This evidence concerns the gene ACLY and cancer.